AZD5462
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for AZD5462, covering 2025-07-04 to 2026-02-18. Get the full timeline:
Most recent: Clinical Trial Update: A Phase IIb Study of AZD5462 in Patients With Chronic Heart Failure [Phase 2]